GSE126960
Characterization of human BRAF mutated melanoma cells that persist after PLX4032 treatment
We performed RNA-seq in parental MEL-XY3 melanoma cells (JM9) and in MEL-XY3 SUR cells obtained in vitro after 5 week treatment with PLX4032 (JM7) Overall design: Transcriptome profile of 2 melanoma cell lines